Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis

• Published in: Frontiers in immunology Vol. 10; p. 151
• Main Authors: Nijhuis, Lotte, Peeters, Janneke G C, Vastert, Sebastiaan J, van Loosdregt, Jorg
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 07.02.2019
• Subjects: Acetylation; Animals; Arthritis, Juvenile - drug therapy; Arthritis, Juvenile - immunology; Chronic Disease; HDAC inhibitor (histone deacetylase inhibitor); Histone Deacetylase Inhibitors - therapeutic use; Histones - immunology; Humans; Immune Tolerance; Immunology; Inflammation - drug therapy; juvenile idiopathic arthritis (JIA); T cells; T-Lymphocytes - immunology; tolerance; acetylation; T cells; tolerance; juvenile idiopathic arthritis (JIA); HDAC inhibitor (histone deacetylase inhibitor)
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2019.00151

Juvenile Idiopathic Arthritis (JIA) is characterized by a loss of immune tolerance. Here, the balance between the activity of effector T (Teff) cells and regulatory T (Treg) cells is disturbed resulting in chronic inflammation in the joints. Presently, therapeutic strategies are predominantly aimed at suppressing immune activation and pro-inflammatory effector mechanisms, ignoring the opportunity to also promote tolerance by boosting the regulatory side of the immune balance. Histone deacetylases (HDACs) can deacetylate both histone and non-histone proteins and have been demonstrated to modulate epigenetic regulation as well as cellular signaling in various cell types. Importantly, HDACs are potent regulators of both Teff cell and Treg cell function and can thus be regarded as attractive therapeutic targets in chronic inflammatory arthritis. HDAC inhibitors (HDACi) have proven therapeutic potential in the cancer field, and are presently being explored for their potential in the treatment of autoimmune diseases. Specific HDACi have already been demonstrated to reduce the secretion of pro-inflammatory cytokines by Teff cells, and promote Treg numbers and suppressive capacity and . In this review, we outline the role of the different classes of HDACs in both Teff cell and Treg cell function. Furthermore, we will review the effect of different HDACi on T cell tolerance and explore their potential as a therapeutic strategy for the treatment of oligoarticular and polyarticular JIA.